| Bangalore, India, August 6, 2014
 
 Biocon  Ltd, Asia's premier biotechnology company, announced today that Biocon  Foundation has won the 'Asia Best CSR  Practices Award 2014' hosted by CMO  Asia at Singapore, as a part of World CSR Congress, in the 'Best Community Initiative' category for its 'Community Cervical Cancer Screening Program'.
 Mr. S. Raman,  Vice President & Head of Biocon Malaysia operations, received the award on  behalf of Biocon Foundation at the 4th Asia Best CSR Practices  Awards held in Singapore on Aug. 1, 2014. The Asia Best CSR Practices Awards recognize corporates in Asia  that have had a significant and positive impact on people, communities and the  environment.  Commenting on the award, Kiran  Mazumdar-Shaw, CMD - Biocon, said, "This  is a significant award as it endorses the very challenging work that we are  doing through our Community Cervical Cancer Screening Program." “Early  detection of cervical cancer through Biocon Foundation's screening program has  led to early treatment at lower cost and greatly enhanced treatment outcomes in  the rural communities we serve,” she added. India has the highest number of deaths from cervical cancer than  any other country. Cervical cancer kills over 72,000 women in India every year,  more than 26% of the 275,000 deaths worldwide. (Source:  Cervical Cancer Free Coalition) The Biocon Foundation’s cervical cancer prevention and control  program is centered around three key service delivery components – community information  and education, accessible screening services & diagnostics and treatment  services. Biocon Foundation trains healthcare workers to provide  reproductive health education to women in underserved communities. The  Foundation has also collaborated with tertiary cancer centres to link  diagnostic, screening and treatment services. This program is rolled out by the  Arogya Raksha Yojana (ARY) clinics in Karnataka, operated by the Foundation. The Foundation’s health workers identify women who seem to be at  risk and preregister them for a screening camp. The women undergo comprehensive  screening by specialists from the tertiary cancer centres who visit the ARY  clinics once a month. The screening process is highly systematic, including a  counseling session. To maintain quality and provide focused attention, the center  limits the number of screenings to around 20 patients a day, the doctor spends  nearly 45 minutes per patient to give quality time and attention to the  patient. So far, hundreds of women have been screened, leading to the detection  of several cancer cases. A doctor conducts  a systematic pelvic examination and PAP smear. While other issues are treated  at the clinic, PAP slides are sent to the Mazumdar Shaw Cancer Centre (MSCC) or  St. John’s Hospital in Bangalore. If abnormalities (precancerous lesions) are  found, patients are counselled to go in for follow-up diagnosis and treatment.  Patients are also advised to repeat the PAP smear test every two years. About Biocon Foundation:
 The Biocon Foundation was set up in 2005 to  make enduring social impact through sustainable community development programs  in the areas of healthcare, education and infrastructure development including  housing and sanitation. Biocon believes its corporate social responsibility  lies in enabling an ecosystem that can deliver affordable and effective  healthcare to the less privileged among India's rural and urban populations.
 The Foundation strongly believes in  collaborative efforts to make a meaningful impact and its initiatives are  directed towards comprehensive programs driven through public private  partnership. It endeavors to impart better learning to the underprivileged  students in the rural schools through various education initiatives, and is  constantly engaged in empowering the communities it serves. For more  information: www.bioconfoundation.org
 
 
 For further information, please contact:
 
 Media Relations
 
 Seema Ahuja
 Phone: +91 080 2808 2808
 Email: seema.ahuja@biocon.com
 
 Rumman Ahamed
 Phone: +91 080 2808 2808
 Email: rumman.ahmed@biocon.com
 
 
 Investor Relations
 
 Saurabh Paliwal
 Phone: +91 95383 80801
 Email:  saurabh.paliwal@biocon.com
 
 
 
 |